Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zyprexa
Pharma
Teva and MedinCell's long-acting schizophrenia med wins in phase 3
The companies formulated a long-acting version of popular antipsychotic olanzapine, which Eli Lilly first marketed in the 90s.
Zoey Becker
May 8, 2024 10:40am
Teva taps Royalty to bankroll long-acting schizophrenia drug
Nov 13, 2023 11:40am
Alkermes' Lybalvi a new litmus test for mental illness marketing
Feb 24, 2022 10:20am
Alkermes gains FDA nod for schizophrenia drug Lybalvi
Jun 1, 2021 9:42am
Lilly CEO to pharma: Stop talking and get going on pricing
Jan 10, 2018 7:33am
Senator blasts 'revolving door' in Washington at Azar hearing
Nov 29, 2017 12:35pm
